FDA Compounding Pharmacy Crackdown Includes Citations For Ribavirin, Propulsid

The citations are part of warning letters issued for compounding of domperidone, a lactation product which is not approved by FDA. The agency issues a Talk Paper that warns breastfeeding women about the safety risks of domperidone.